# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213809-20-000013
Filing Date
2020-02-24
Accepted
2020-02-24 09:29:51
Documents
22
Period of Report
2020-02-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a8-kdyadicvttachivingg.htm | 8-K | 36248
2 | EX-99.1 | ex991dyadicannouncesac.htm | EX-99.1 | 17137
3 | EX-99.2 | a200219ecfg15romehuuskon.htm | EX-99.2 | 22824
4 |  | a200219ecfg15romehuuskon001.jpg | GRAPHIC | 91710
5 |  | a200219ecfg15romehuuskon002.jpg | GRAPHIC | 139245
6 |  | a200219ecfg15romehuuskon003.jpg | GRAPHIC | 101102
7 |  | a200219ecfg15romehuuskon004.jpg | GRAPHIC | 122342
8 |  | a200219ecfg15romehuuskon005.jpg | GRAPHIC | 101707
9 |  | a200219ecfg15romehuuskon006.jpg | GRAPHIC | 118074
10 |  | a200219ecfg15romehuuskon007.jpg | GRAPHIC | 124717
11 |  | a200219ecfg15romehuuskon008.jpg | GRAPHIC | 107529
12 |  | a200219ecfg15romehuuskon009.jpg | GRAPHIC | 99540
13 |  | a200219ecfg15romehuuskon010.jpg | GRAPHIC | 99283
14 |  | a200219ecfg15romehuuskon011.jpg | GRAPHIC | 99912
15 |  | a200219ecfg15romehuuskon012.jpg | GRAPHIC | 109624
16 |  | a200219ecfg15romehuuskon013.jpg | GRAPHIC | 116186
17 |  | a200219ecfg15romehuuskon014.jpg | GRAPHIC | 123554
18 |  | a200219ecfg15romehuuskon015.jpg | GRAPHIC | 93634
19 |  | a200219ecfg15romehuuskon016.jpg | GRAPHIC | 140217
20 |  | a200219ecfg15romehuuskon017.jpg | GRAPHIC | 89599
21 |  | a200219ecfg15romehuuskon018.jpg | GRAPHIC | 40996
22 |  | image01.jpg | GRAPHIC | 16790
| Complete submission text file | 0001213809-20-000013.txt |  | 2739769

Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 20642268
SIC: 2836 Biological Products, (No Diagnostic Substances)